Table 2.
Associations between maspin expression and clinicopathological factors in adenocarcinoma of the uterine cervix
| Maspin expression | ||||
| Positive | Negative | P-value | ||
| FIGO stage | ||||
| I and II | 20 | 13 | 0.072 | |
| III and IV | 12 | 1 | ||
| Tumor size | ||||
| < 40mm | 13 | 8 | 0.179 | |
| ≥ 40mm | 19 | 4 | ||
| Lymph node metastasis | ||||
| Present | 19 | 11 | 0.279 | |
| Absent | 11 | 2 | ||
| Histological subtype | ||||
| Mucinous | 10 | 10 | 0.042* | |
| Endometrioid | 13 | 3 | ||
| Others | 9 | 1 | ||
| Recurrence | ||||
| Present | 17 | 2 | 0.022* | |
| Absent | 15 | 12 | ||
*P < 0.05.
FIGO, The International Federation of Gynecology and Obstetrics.